These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1365986)

  • 1. [The clinical picture of MS disease is now more complete].
    Panelius M; Salmi AA
    Duodecim; 1992; 108(1):73-5. PubMed ID: 1365986
    [No Abstract]   [Full Text] [Related]  

  • 2. Current concepts of the cellular and molecular pathophysiology of multiple sclerosis.
    Greenstein JI
    Dev Neurobiol; 2007 Aug; 67(9):1248-65. PubMed ID: 17514718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions.
    Frohman EM; Filippi M; Stuve O; Waxman SG; Corboy J; Phillips JT; Lucchinetti C; Wilken J; Karandikar N; Hemmer B; Monson N; De Keyser J; Hartung H; Steinman L; Oksenberg JR; Cree BA; Hauser S; Racke MK
    Arch Neurol; 2005 Sep; 62(9):1345-56. PubMed ID: 16157741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.
    Camiña-Tato M; Morcillo-Suárez C; Navarro A; Fernández M; Horga A; Montalban X; Comabella M
    J Neuroimmunol; 2009 Aug; 213(1-2):142-7. PubMed ID: 19515430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis.
    Ramagopalan SV; Deluca GC; Morrison KM; Herrera BM; Dyment DA; Orton S; Bihoreau MT; Degenhardt A; Pugliatti M; Sadovnick AD; Sotgiu S; Ebers GC
    J Neuroimmunol; 2007 May; 186(1-2):156-60. PubMed ID: 17376543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic susceptibility to multiple sclerosis (MS). INSERM Network of Clinical Research on the Genetic Susceptibility to MS].
    Fontaine B
    Rev Neurol (Paris); 1998 Sep; 154(8-9):601-5. PubMed ID: 9809375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases.
    Kümpfel T; Hoffmann LA; Pellkofer H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
    Neurology; 2008 Nov; 71(22):1812-20. PubMed ID: 19029521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA antigens in multiple sclerosis in Alsace.
    Rumbach L; Tongio MM; Warter JM; Marescaux C; Grange D; Mayer S; Collard M
    Biomed Pharmacother; 1985; 39(7):385-9. PubMed ID: 3830266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible link between multiple sclerosis and Creutzfeldt-Jakob disease based on clinical, genetic, pathological and immunological evidence involving Acinetobacter bacteria.
    Ebringer A; Rashid T; Wilson C; Boden R; Thompson E
    Med Hypotheses; 2005; 64(3):487-94. PubMed ID: 15617854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-10 promoter polymorphism in multiple sclerosis: association with disease progression.
    Almeras L; Meresse B; Seze J; De Lefranc D; Dubucquoi S; Fajardy I; Vermersch P; Prin L
    Eur Cytokine Netw; 2002; 13(2):200-6. PubMed ID: 12101075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis: disease biomarkers as indicated by pathophysiology.
    Berger T; Reindl M
    J Neurol Sci; 2007 Aug; 259(1-2):21-6. PubMed ID: 17367811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders.
    Kira J; Kanai T; Nishimura Y; Yamasaki K; Matsushita S; Kawano Y; Hasuo K; Tobimatsu S; Kobayashi T
    Ann Neurol; 1996 Oct; 40(4):569-74. PubMed ID: 8871575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evoked potential testing in relatives of multiple sclerosis patients.
    Nuwer MR; Visscher BR; Packwood JW; Namerow NS
    Ann Neurol; 1985 Jul; 18(1):30-4. PubMed ID: 4037748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR15 is associated with lower age at onset in multiple sclerosis.
    Masterman T; Ligers A; Olsson T; Andersson M; Olerup O; Hillert J
    Ann Neurol; 2000 Aug; 48(2):211-9. PubMed ID: 10939572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAPS and MS: two diseases or an MS mimic?
    Sriram S
    Neurology; 2008 Mar; 70(13 Pt 2):1077-8. PubMed ID: 18362272
    [No Abstract]   [Full Text] [Related]  

  • 16. Apolipoprotein E genotype does not influence the progression of multiple sclerosis.
    Savettieri G; Andreoli V; Bonavita S; Cittadella R; Caltagirone C; Fazio MC; Girlanda P; Le Pira F; Liguori M; Logroscino G; Lugaresi A; Nocentini U; Reggio A; Salemi G; Serra P; Tedeschi G; Toma L; Trojano M; Valentino P; Quattrone A
    J Neurol; 2003 Sep; 250(9):1094-8. PubMed ID: 14504972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical demographics of multiplex families with multiple sclerosis. Multiple Sclerosis Genetics Group.
    Ann Neurol; 1998 Apr; 43(4):530-4. PubMed ID: 9546337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis in 3 gipsy and 2 partly gipsy subjects (a clinical and immunogenetic study).
    Pálffy G; Gyódi E; Petrányi G
    Acta Med Hung; 1986; 43(1):31-7. PubMed ID: 3774417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis.
    Cournu-Rebeix I; Génin E; Leray E; Babron MC; Cohen J; Gout C; Alizadeh M; Perdry H; Semana G; Brassat D; Clerget-Darpoux F; Yaouanq J; Edan G; Rosenheim M; Fontaine B
    Genes Immun; 2008 Sep; 9(6):570-4. PubMed ID: 18615093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy and multiple sclerosis.
    Houtchens MK
    Semin Neurol; 2007 Nov; 27(5):434-41. PubMed ID: 17940922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.